We are live on
!
Find out more
MWVC
Morgens Waterfall Vintiadis & Co Portfolio holdings
AUM
$81.2M
1-Year Est. Return
86.87%
This Fund
S&P 500
This Quarter
Est. Return
+7.35%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$159M
AUM Growth
+$3.07M
(+2%)
Cap. Flow
-$2.64M
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
61
New
16
Increased
8
Reduced
5
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$7.51M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$4.51M |
| 3 |
CAVM
Cavium, Inc.
CAVM
|
+$4.42M |
| 4 |
Goldman Sachs
GS
|
+$4.28M |
| 5 |
Apple
AAPL
|
+$4.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insulet
PODD
|
+$7.2M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$5.05M |
| 3 |
Medtronic
MDT
|
+$4.29M |
| 4 |
Delta Air Lines
DAL
|
+$4.27M |
| 5 |
American Airlines Group
AAL
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.73% |
| 2 | Technology | 20.89% |
| 3 | Financials | 15.53% |
| 4 | Communication Services | 10.21% |
| 5 | Consumer Discretionary | 9.39% |
Similar funds
RTC
SPW
MC
FPAM
BCM
QM
FF
AGFVA
Morgens Waterfall Vintiadis & Co's Q2 2015 Portfolio in Review
As of Q2 2015, Morgens Waterfall Vintiadis & Co held 61 positions worth $159M, up 2% from $156M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Morgens Waterfall Vintiadis & Co's Q2 2015 filing shows 16 new, 8 increased, 5 reduced and 18 closed positions. Its largest new stake was JPMorgan Chase: 115,000 shares worth $7.79M. The largest sale was Insulet, an estimated $7.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- Morgens Waterfall Vintiadis & Co's largest Q2 2015 buy was JPMorgan Chase: 115,000 shares worth $7.79M.
- Morgens Waterfall Vintiadis & Co added most to Apple in Q2 2015, an estimated $4.22M increase.
- Morgens Waterfall Vintiadis & Co's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.99M.
- Morgens Waterfall Vintiadis & Co fully exited Insulet in Q2 2015, selling an estimated $7.2M.
- Morgens Waterfall Vintiadis & Co's ten largest holdings make up 41% of its $159M portfolio in Q2 2015.
- Morgens Waterfall Vintiadis & Co opened 16 new positions and closed 18 in Q2 2015.
- Morgens Waterfall Vintiadis & Co's portfolio value rose 2% quarter-over-quarter to $159M.
Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2015, filed 3 Aug 2015.